Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging
Dennie Meijer, Maarten L. Donswijk, Yves J. L. Bodar, Pim J. van Leeuwen, Henk G. van der Poel, Wouter V. Vogel, Jakko A. Nieuwenhuijzen, N. Harry Hendrikse, Daniela E. Oprea‐Lager, André N. Vis
Abstract
In the presence of BCP, a high proportion of patients already had disease metastatic to the pelvic lymph nodes or showed evidence of distant metastases, as indicated by PSMA PET/CT. Higher PSA levels after RARP and positive pathologic lymph node status were significantly associated with metastases outside the prostatic fossa. In patients with BCP, PSMA PET/CT imaging is warranted to guide salvage treatment strategies.
Topics & Concepts
MedicineInterquartile rangeProstatectomyProstate cancerBiochemical recurrenceGlutamate carboxypeptidase IIProstate-specific antigenStandardized uptake valueNuclear medicineUrologyPositron emission tomographyPET-CTRadiologyCancerInternal medicineProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentUrologic and reproductive health conditions